+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Association between ERCC2 polymorphisms and glioma risk: a meta-analysis



Association between ERCC2 polymorphisms and glioma risk: a meta-analysis



Asian Pacific Journal of Cancer Prevention 15(11): 4417-4422



ERCC2 is an essential component of the nucleotide excision repair pathway which is involved in the effective maintenance of genome integrity. Association studies on ERCC2 polymorphisms and glioma risk have yielded inconclusive results. This meta-analysis was performed to gain a better insight into the relationship between ERCC2 polymorphisms and glioma risk. A systematic literature search updated to December 2, 2013 was performed in the Pubmed and EMBASE databases. Crude pooled odds ratios (ORs) with their corresponding 95% confidence intervals (95% CIs) were used to estimate the association between ERCC2 polymorphisms and glioma risk under a suitable effect model according to heterogeneity. All analyses were performed using Review Manager 5 (version 5.2) and STATA (version 12.0). The combined results demonstrated rs13181 to be significantly associated with glioma risk (G allele versus T allele: OR=1.15, 95% CI=1.05-1.26, P=0.002; dominant model: OR=1.22, 95% CI=1.07-1.39, P=0.002; recessive model: OR=1.18, 95% CI=0.98-1.41, P=0.070). We also found that rs13181 acts in an allele dose-dependent manner (GG versus TT: OR=1.30, 95% CI=1.07-1.57, P=0.009; TG versus TT: OR=1.20, 95%=CI 1.05-1.37, P=0.009; trend test, P=0.004). However, no evidence was found in analyses for the association between other 3 ERCC2 polymorphisms (rs238406, rs1799793, and rs1052555) and susceptibility to glioma development. Our meta-analysis suggests that rs13181 is significantly associated with glioma risk in an allele dose-dependent manner, whereas, 3 other ERCC2 polymorphisms (rs238406, rs1799793, and rs1052555) may have no influence.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 051671591

Download citation: RISBibTeXText

PMID: 24969862


Related references

Association of ERCC1 C8092A and ERCC2 Lys751Gln polymorphisms with the risk of glioma: a meta-analysis. Plos one 9(4): E95966, 2014

Association between ERCC1 C8092A and ERCC2 K751Q polymorphisms and risk of adult glioma: a meta-analysis. Tumour Biology 35(4): 3211-3221, 2014

Association between the ERCC2 rs13181 polymorphism and the risk of glioma: a meta-analysis. Genetics and Molecular Research 14(4): 12577-12584, 2015

Association between polymorphisms in ERCC2 gene and oral cancer risk: evidence from a meta-analysis. Bmc Cancer 13: 594, 2013

Association of ERCC1 rs3212986 & ERCC2 rs13181 polymorphisms with the risk of glioma. Pakistan Journal of Medical Sciences 30(6): 1409-1414, 2015

Association of single-nucleotide polymorphisms in ERCC1 and ERCC2 with glioma risk. Tumour Biology 35(8): 7451-7457, 2014

Systematic review on the association between ERCC1 rs3212986 and ERCC2 rs13181 polymorphisms and glioma risk. Genetics and Molecular Research 14(1): 2868-2875, 2015

Association between XRCC1 gene polymorphisms and risk of glioma development: a meta-analysis. Asian Pacific Journal of Cancer Prevention 13(9): 4783-4788, 2012

An Updated and Comprehensive Meta-Analysis of Association Between Seven Hot Loci Polymorphisms from Eight GWAS and Glioma Risk. Molecular Neurobiology 53(7): 4397-4405, 2016

Association between common polymorphisms in ERCC gene and glioma risk: A meta-analysis of 15 studies. Medicine 96(20): E6832, 2017

Association between DNA repair gene polymorphisms and risk of glioma: a systematic review and meta-analysis. Neuro-Oncology 16(6): 807-814, 2014

Association between the XRCC1 polymorphisms and glioma risk: a meta-analysis of case-control studies. Plos one 8(1): E55597, 2013

ERCC2 Lys751Gln and Asp312Asn polymorphisms and gastric cancer risk: a meta-analysis. Journal of Cancer Research and Clinical Oncology 137(6): 939-946, 2011

Polymorphisms in ERCC 2 and ERCC 5 and Risk of Prostate Cancer: A Meta-Analysis and Systematic Review. Journal of Cancer 9(16): 2786-2794, 2018

Complex association between ERCC2 gene polymorphisms, gender, smoking and the susceptibility to bladder cancer: a meta-analysis. Tumour Biology 35(6): 5245-5257, 2014